Canada markets open in 8 hours 42 minutes

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.03-0.52 (-1.22%)
At close: 04:00PM EDT
42.28 +0.25 (+0.59%)
After hours: 05:49PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.12B
Enterprise Value 5.25B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)7.74
Price/Book (mrq)16.05
Enterprise Value/Revenue 6.66
Enterprise Value/EBITDA -22.24

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 318.00%
S&P500 52-Week Change 328.64%
52 Week High 354.44
52 Week Low 332.87
50-Day Moving Average 348.10
200-Day Moving Average 345.21

Share Statistics

Avg Vol (3 month) 31.23M
Avg Vol (10 day) 31.03M
Shares Outstanding 5145.75M
Implied Shares Outstanding 6145.75M
Float 8144.53M
% Held by Insiders 10.86%
% Held by Institutions 1100.94%
Shares Short (Feb 29, 2024) 49.11M
Short Ratio (Feb 29, 2024) 47.22
Short % of Float (Feb 29, 2024) 47.38%
Short % of Shares Outstanding (Feb 29, 2024) 46.25%
Shares Short (prior month Jan 31, 2024) 48.45M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -46.50%
Operating Margin (ttm)4.79%

Management Effectiveness

Return on Assets (ttm)-7.51%
Return on Equity (ttm)-76.34%

Income Statement

Revenue (ttm)787.65M
Revenue Per Share (ttm)5.50
Quarterly Revenue Growth (yoy)113.60%
Gross Profit (ttm)N/A
EBITDA -319.22M
Net Income Avi to Common (ttm)-366.29M
Diluted EPS (ttm)-2.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.34B
Total Cash Per Share (mrq)16.04
Total Debt (mrq)1.45B
Total Debt/Equity (mrq)375.90%
Current Ratio (mrq)5.90
Book Value Per Share (mrq)2.68

Cash Flow Statement

Operating Cash Flow (ttm)-307.51M
Levered Free Cash Flow (ttm)-159.99M